Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Endocr Rev 2012 Dec 12;33(6):981-1030. Epub 2012 Oct 12.

Medical School, University of Athens (E.D.-K.), Athens GR-14578, Greece.

Polycystic ovary syndrome (PCOS) is now recognized as an important metabolic as well as reproductive disorder conferring substantially increased risk for type 2 diabetes. Affected women have marked insulin resistance, independent of obesity. This article summarizes the state of the science since we last reviewed the field in the Endocrine Reviews in 1997. There is general agreement that obese women with PCOS are insulin resistant, but some groups of lean affected women may have normal insulin sensitivity. There is a post-binding defect in receptor signaling likely due to increased receptor and insulin receptor substrate-1 serine phosphorylation that selectively affects metabolic but not mitogenic pathways in classic insulin target tissues and in the ovary. Constitutive activation of serine kinases in the MAPK-ERK pathway may contribute to resistance to insulin's metabolic actions in skeletal muscle. Insulin functions as a co-gonadotropin through its cognate receptor to modulate ovarian steroidogenesis. Genetic disruption of insulin signaling in the brain has indicated that this pathway is important for ovulation and body weight regulation. These insights have been directly translated into a novel therapy for PCOS with insulin-sensitizing drugs. Furthermore, androgens contribute to insulin resistance in PCOS. PCOS may also have developmental origins due to androgen exposure at critical periods or to intrauterine growth restriction. PCOS is a complex genetic disease, and first-degree relatives have reproductive and metabolic phenotypes. Several PCOS genetic susceptibility loci have been mapped and replicated. Some of the same susceptibility genes contribute to disease risk in Chinese and European PCOS populations, suggesting that PCOS is an ancient trait.

Download full-text PDF

Source
http://dx.doi.org/10.1210/er.2011-1034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393155PMC
December 2012
3 Reads

Publication Analysis

Top Keywords

insulin resistance
12
insulin
9
pcos
9
polycystic ovary
8
ovary syndrome
8
receptor modulate
4
modulate ovarian
4
ovarian steroidogenesis
4
skeletal muscle
4
muscle insulin
4
cognate receptor
4
functions co-gonadotropin
4
steroidogenesis genetic
4
co-gonadotropin cognate
4
insulin functions
4
insulin signaling
4
body weight
4
ovulation body
4
weight regulation
4
regulation insights
4

References

(Supplied by CrossRef)
The genetics of aging
Finch et al.
Annu Rev Genomics Hum Genet 2001
Hippocrates: Diseases of Women 1
Hanson et al.
Signs (Chic) 1975
De Sedibus et Causis Morborum per Anatomen Indagata (The seats and causes of diseases investigated by anatomy)
Morgagni et al.
1765
Le virilisme et son association à l'insuffisance glycolytique (diabète des femmes à barbe)
Achard et al.
Bull Acad Natl Med (Paris) 1921
La différentiation sexuelle. Facteur determinant des formes de l'obesité
Vague et al.
Presse Med 1947
Mutations in the insulin receptor gene
Taylor et al.
Endocr Rev 1992

Similar Publications